A buzz is building around Moleculin Biotech that's pushing shares higher.
The clinical-stage pharma firm announced yesterday morning that its president and CEO, Walter Klemp, will present at the HC Wainwright Global Investment Conference being held May 23-26 in Miami, FL.
The news could be an indication Moleculin is pursuing another round of funding, or the CEO could be planning on making a splash at the conference with a big announcement.
Whatever the case, it could provide a key catalyst for the stock in the days ahead. Traders are buying today, so they'll be in prime position in case news breaks as early as Monday.
MBRX is currently up 35.7% on active premarket trading volume.